{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T00:31:19Z","timestamp":1764721879723,"version":"3.46.0"},"reference-count":12,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,12,2]]},"DOI":"10.7759\/cureus.98336","type":"journal-article","created":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T00:28:46Z","timestamp":1764721726000},"source":"Crossref","is-referenced-by-count":0,"title":["Trapped in Silence: Severe Catatonia From Anti-N-Methyl-D-Aspartate (NMDA) Receptor Encephalitis in a Neurofibromatosis Type 1 Patient With Craniopharyngioma"],"prefix":"10.7759","author":[{"given":"Kirubel Z","family":"Gebreselassie","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tizita","family":"Negash","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pablo Andres","family":"Bravo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wayne","family":"Chiu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1002\/ana.21050","article-title":"Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma","volume":"61","author":"Dalmau J","year":"2007","unstructured":"Dalmau J, T\u00fcz\u00fcn E, Wu HY, et al.. Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma. Ann Neurol. 2007, 61:25-36. 10.1002\/ana.21050","journal-title":"Ann Neurol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3390\/brainsci15050518","article-title":"Anti-NMDA receptor encephalitis: a narrative review","volume":"15","author":"P\u0103dureanu V","year":"2025","unstructured":"P\u0103dureanu V, Dop D, P\u0103dureanu R, P\u00eer\u0219coveanu DF, Olaru G, Streata I, Bug\u0103 AM.  Anti-NMDA receptor encephalitis: a narrative review. Brain Sci. 2025, 15:14-6. 10.3390\/brainsci15050518","journal-title":"Brain Sci"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1096\u20118628(19990326)89:1<1::AID\u2011AJMG3>3.0.CO;2\u20118","article-title":"Epidemiology of neurofibromatosis type 1","volume":"89","author":"Friedman JM","year":"1999","unstructured":"Friedman JM. Epidemiology of neurofibromatosis type 1. Am J Med Genet. 1999, 89:1-6. 10.1002\/(SICI)1096\u20118628(19990326)89:1&lt;1::AID\u2011AJMG3&gt;3.0.CO;2\u20118","journal-title":"Am J Med Genet"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2007-3204","article-title":"Neurofibromatosis type 1 revisited","volume":"123","author":"Williams VC","year":"2009","unstructured":"Williams VC, Lucas J, Babcock MA, Gutmann DH, Korf B, Maria BL. Neurofibromatosis type 1 revisited. Pediatrics. 2009, 123:124-33. 10.1542\/peds.2007-3204","journal-title":"Pediatrics"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1111\/pcn.12867","article-title":"Catatonia in patients with anti-NMDA receptor encephalitis","volume":"73","author":"Espinola-Nadurille M","year":"2019","unstructured":"Espinola-Nadurille M, Flores-Rivera J, Rivas-Alonso V, et al.. Catatonia in patients with anti-NMDA receptor encephalitis. Psychiatry Clin Neurosci. 2019, 73:574-80. 10.1111\/pcn.12867","journal-title":"Psychiatry Clin Neurosci"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(10)70253-2","article-title":"Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis","volume":"10","author":"Dalmau J","year":"2011","unstructured":"Dalmau J, Lancaster E, Martinez-Hernandez E, Rosenfeld MR, Balice-Gordon R. Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis. Lancet Neurol. 2011, 10:63-74. 10.1016\/S1474-4422(10)70253-2","journal-title":"Lancet Neurol"},{"key":"ref7","article-title":"Anti-NMDA Receptor Encephalitis","author":"Samanta D","year":"2019","unstructured":"Samanta D, Lui F. Anti-NMDA Receptor Encephalitis. StatPearls Publishing, Treasure Island, FL; 2019."},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.2217\/cns-2016-0024","article-title":"The role of the immune system in neurofibromatosis type 1-associated nervous system tumors","volume":"6","author":"Karmakar S","year":"2017","unstructured":"Karmakar S, Reilly KM. The role of the immune system in neurofibromatosis type 1-associated nervous system tumors. CNS Oncol. 2017, 6:45-60. 10.2217\/cns-2016-0024","journal-title":"CNS Oncol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.25259\/CSDM_143_2023","article-title":"Coexistence of neurofibromatosis\u202f1 and vitiligo","volume":"3","author":"Ramamoorthy\u202fL","year":"2023","unstructured":"Ramamoorthy\u202fL, Rout\u202fN. Coexistence of neurofibromatosis\u202f1 and vitiligo.  CNS Oncol. 2023, 3:126. 10.25259\/CSDM_143_2023","journal-title":"CNS Oncol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1111\/j.1525-1470.2008.00692.x","article-title":"Autoimmune diseases associated with neurofibromatosis type 1","volume":"25","author":"Nanda A","year":"2008","unstructured":"Nanda A. Autoimmune diseases associated with neurofibromatosis type 1. Pediatr Dermatol. 2008, 25:392-3. 10.1111\/j.1525-1470.2008.00692.x","journal-title":"Pediatr Dermatol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1148\/rg.220173","article-title":"Anti-NMDA-receptor encephalitis","volume":"42","author":"Klontzas ME","year":"2022","unstructured":"Klontzas ME, Kearns C, Sheikhbahaei S, Cornejo P. Anti-NMDA-receptor encephalitis. Radiographics. 2022, 42:E199-200. 10.1148\/rg.220173","journal-title":"Radiographics"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2023.578271","article-title":"Electroconvulsive therapy for catatonia in anti-NMDA receptor encephalitis: a case series","volume":"386","author":"Wadi L","year":"2024","unstructured":"Wadi L, Mandge V. Electroconvulsive therapy for catatonia in anti-NMDA receptor encephalitis: a case series. J Neuroimmunol. 2024, 386:578271. 10.1016\/j.jneuroim.2023.578271","journal-title":"J Neuroimmunol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/389754-trapped-in-silence-severe-catatonia-from-anti-n-methyl-d-aspartate-nmda-receptor-encephalitis-in-a-neurofibromatosis-type-1-patient-with-craniopharyngioma","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T00:28:47Z","timestamp":1764721727000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/389754-trapped-in-silence-severe-catatonia-from-anti-n-methyl-d-aspartate-nmda-receptor-encephalitis-in-a-neurofibromatosis-type-1-patient-with-craniopharyngioma"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,2]]},"references-count":12,"URL":"https:\/\/doi.org\/10.7759\/cureus.98336","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12,2]]}}}